You know that feeling when your eyes just won’t stop stinging, burning, or feeling like there’s sand stuck in them? It’s the worst. And if you’re dealing with dry eyes, you’re not alone—more than 16 million Americans are right there with you.
This can happen when eyes stop producing enough tears or when tears evaporate too quickly. But regardless of how this issue starts, chronic dry eye is a cycle that disrupts the natural tear balance, and it can lead to various symptoms such as burning, stinging, grittiness or a sensation of dryness.
If left untreated, ongoing inflammation can cause long-term damage to your corneas and may even lead to vision loss. The cycle perpetuates itself as inflammation disrupts tear production and quality, making it even harder to repair the damage caused by dry eye disease.
The hidden toll of dry eyes
Dry eye disease impacts much more than just your vision—it can have a profound effect on your daily life. Tasks that once seemed effortless, like concentrating at work, enjoying your favorite hobbies or even getting a good night’s sleep, can become frustratingly difficult. The constant discomfort may even make you hesitant to engage in social activities or exercise, leaving you feeling isolated. Over time, the emotional strain of dealing with persistent eye irritation can wear you down, affecting your overall mood and sense of well-being.
Many people with dry eyes rely on temporary fixes like artificial tears to manage the discomfort. However, these quick solutions rarely address the underlying inflammation that is at the root of the problem. As a result, symptoms may intensify, and it can become even harder to find relief. Unfortunately, it’s often only when the condition starts to severely disrupt daily routines that people begin to realize the full extent of the damage being done.
But the good news is that lasting relief is possible. With proper treatment that targets the source of dry eye disease, you can break the cycle, reduce discomfort and restore your eye health. No more just getting by. No more waiting for relief. VEVYE® (cyclosporine ophthalmic solution) 0.1% can help you feel like yourself again.
VEVYE: A different kind of dry eye treatment
Meet VEVYE a prescription eye drop that works fast, in some cases as soon as 15 days, while feeling gentle—so you can get the relief you’ve been looking for.
Why VEVYE? -It’s not just another eye drop
VEVYE is designed to treat the signs and symptoms of dry eye disease, targeting the underlying inflammation that causes discomfort.
The VEVYE Difference:
• Innovative Formula: VEVYE enhances the penetration of cyclosporine into the cornea, directly targeting dry eye inflammation.
• Relief that starts early: Patients reported improvement in dry eye symptoms within the first month.
• Safety Profile: VEVYE maximizes comfort, with 99.8% of patients in clinical studies reporting no or only mild burning or stinging upon application.
VEVYE works fast, so you can leave dry eyes behind
In clinical trials:
• Day 15: VEVYE started to repair the physical damage caused by dry eye disease.
• Day 29: VEVYE increased natural tear production to restore moisture.
• Month 12: On average, patients had tear production levels nearly back to normal.
Do dry eyes affect your daily life? VEVYE could help
Patients using VEVYE, on average, reported improvement in:
• Dry, gritty or burning sensations
• Fluctuating vision clarity
• Comfort when reading, driving at night and looking at digital screens
No more constant discomfort—just eyes that feel like yours again.
Applying VEVYE is simple:
• Use one drop per eye, every 12 hours.
• Each bottle lasts 30 days when used properly.
• Remove contact lenses before applying. Wait 15 minutes after using VEVYE before reinserting contacts.
VEVYE® Access For All: Making treatment more affordable
Harrow, the maker of VEVYE, believes that every patient deserves fast, easy and affordable access to medication. That’s why the “VEVYE® Access for All” program was created—to help ensure that cost and insurance barriers do not prevent patients from receiving the treatments their doctors prescribe.
• No insurance barriers: No need for prior authorizations, and no unexpected costs.
• No compromises: Get the treatment your doctor recommends without having to settle for alternatives.
• Affordable options for all:
− Commercially insured patients may pay as little as $0* per prescription.
− Eligible patients without commercial insurance coverage have access to a $59* cash-pay option.
With VEVYE® Access for All, patients can receive the relief they need—without unnecessary obstacles.
*Terms and Conditions apply. Visit vevye.com/accessforall for complete terms and conditions.
Is VEVYE right for you?
Talk to your doctor today about whether VEVYE is the right treatment for your dry eye disease.
Want to learn more? Visit vevye.com for more information and to download the Doctor Discussion Guide.
BRIEF SUMMARY – PLEASE SEE THE VEVYE PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION
INDICATION AND USAGE
VEVYE® (cyclosporine ophthalmic solution) 0.1% is a prescription drop used to treat the signs and symptoms of dry eye disease.
Dosage:
Apply one drop of VEVYE twice a day in each eye approximately 12 hours apart.
Pediatric/ Geriatric Use:
Safety and effectiveness in pediatric patients below the age of 18 years have not been established. No overall difference in safety or effectiveness has been observed between elderly and younger patients.
IMPORTANT SAFETY INFORMATION
• Care should be taken to not touch the eye or other surfaces with the bottle tip to avoid potential for eye injury and/or contamination.
• Contact lenses should be removed prior to applying VEVYE and may be reinserted 15 minutes following administration.
• The most common side effects include eye irritation (8%) and temporary blurred vision (3%).
To report SUSPECTED ADVERSE REACTIONS, contact Harrow at 1-833-442-7769 or FDA at 1-800-FDA-1088 or fda.gov/medwatch. For additional information about VEVYE please see Full Prescribing information at vevye.com.
VEVYE and the VEVYE logo are registered trademarks of Novaliq GmbH. Harrow IP, LLC owns the registered trademarks for the HARROW logo. © 2025 All Rights Reserved. VYE-00282 05/25
